Association between CYP17 polymorphisms and the development of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 10, 1998, Pages 945-949

  Helzlsouer, Kathy J ^a,d   Huang, Han Yao ^a   Strickland, Paul T ^b   Hoffman, Sandra ^a   Alberg, Anthony J ^a   Comstock, George W ^a   Bell, Douglas A ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b The Johns Hopkins University   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN; STEROID HORMONE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; STEROID METABOLISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MARYLAND; MENARCHE; MENOPAUSE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0031711028     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Helzlsouer, K. J., Alberg, A. I., Bush, T L., Longcope, C., Gordon, G. B., and Comstock, G W. A prospective study of endogenous hormones and breast cancer. Cancer Detect. Prev., 18: 79-85, 1994.
2. Helzlsouer, K J., Gordon, G B , Alberg, A. J., Bush, T. L , and Comstock, G. W. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res., 52: 1-4, 1992
3. Gordon, G B., Bush, T. L., Helzlsouer, K. J., Miller, S. R., and Comstock, G. W. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res., 50: 3859-3862, 1990.
4. Barrett-Connor, E., Friedlander, N. J., and Khaw, K T. Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res , 50: 6571-6574, 1990
5. Garland, C. F., Friedlander, N. J., Barrett-Connor, E., and Khaw, K. T. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am. J. Epidemiol , 135: 1220-1230, 1992.
6. Thomas, H. V., Key, T. J., Allen, D. S., Moore, J. W., Dowsett, M., Fentiman, I. S , and Wang, D. Y. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the Island of Guernsey. Br. J Cancer, 76: 401-405, 1997.
7. Thomas, H V., Key, T. J., Allen, D. S., Moore, J. W , Dowsett, M , Fentiman, I S., and Wang, D. Y. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the Island of Guernsey. Br. J. Cancer, 75: 1075-1079, 1997.
8. Zelemuch-Jacquotte, A , Bruning, P. F., Bonfrer, J M , Koenig, K. L., Shore, R. E., Kim, M. Y., Pasternack, B S., and Toniolo, P. Relationship of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am. J Epidemiol., 145: 1030-1038, 1997.
9. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L , Shore, R. E., Strax, P., and Pasternack, B. W. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst , 87 190-197, 1995.
10. Berrino, F., Muti, P., Micheli, A., Bolelli, G., Krogh, V., Sciajno, R , Pisani, P , Panico, S., and Secreto, G. Serum sex hormone levels after menopause and subsequent breast cancer J. Natl. Cancer Inst , 88: 291-296, 1996.
11. Dorgan, J. F , Longcope, C., Stephenson, H E., Jr., Falk, R. T , Miller, R., Franz, C., Kahle, L , Campbell, W. S., Tangrea, J. A., and Schatzkin, A. Serum sex hormone levels are related to breast cancer risk in postmenopausal women Environ. Health Perspect., 105 (Suppl. 3): 583-585, 1997.
12. Brentano, S. T , Picado-Leonard, J., Mellon, S. H., Moore, C. C. D., and Miller, W. L. Tissue-specific cyclic adenosine 3′,5′-monophosphate-induces, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol. Endocrinol., 4: 1972-1979, 1990.
13. Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J . Novelli, P., Franks, S., and Williamson, R. Polycyslic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol. Genet., 3: 1873-1876, 1994.
14. Kadonago, J T., Jones, K. A., and Tjian, R. Promoter-specific activation of RNA polymerase II transcription by Spl. Trends Biochem Sci., 11: 20-23, 1986.
15. Feigelson, H. S., Shames, L. S., Pike, M C., Coetzee, G. A., Stanczyk, F. Z., and Henderson, B. E. Cytochrome P450c17α Gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res., 58: 585-587, 1998.
16. Feigelson, H. S., Coetzee, G. A., Kolonel, L N., Ross, R. K , and Henderson, B. E. A polymorphism in the CYP17 gene increases the risk of breast cancer Cancer Res , 57: 1063-1065, 1997.
17. Final Maryland Cancer Registry (MCR) Data Report. Northwest Region, Maryland Cancer Registry. Bel Air, Maryland: Tri-Analytics, Inc., 1993.
18. Miller, S. A., Dykes, D. D., and Polesky, H. F A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res., 16: 1215, 1988.
19. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual, pp. 458-459. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982